Aldeyra Therapeutics (NASDAQ:ALDX) Given “Buy” Rating at HC Wainwright
Aldeyra Therapeutics (NASDAQ:ALDX – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a research report issued on Monday,Benzinga reports. They currently have a $10.00 price target on the biotechnology company’s stock. HC Wainwright’s target price points to a potential upside of 62.07% from the company’s current price. […]
Aldeyra Therapeutics (NASDAQ:ALDX – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a research report issued on Monday,Benzinga reports. They currently have a $10.00 price target on the biotechnology company’s stock. HC Wainwright’s target price points to a potential upside of 62.07% from the company’s current price. […]
